VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SPRO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SPROSpero Therapeutics, Inc.
$0.90$52M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSPROQuarterly Financials

Spero Therapeutics, Inc. (SPRO) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Spero Therapeutics, Inc. (SPRO) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

SPRO Income Statement

Quarterly statement

SPRO Income Statement

Spero Therapeutics, Inc. (SPRO) annual income statement — 11-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue00258K39.66M3.05M11.8M5.87M15.04M13.47M10.2M4.2M73.52M25.47M2.72M2.07M46.35M1.08M896K247K2.74M
Revenue Growth %-100%-100%-95.61%163.61%-77.37%15.74%39.72%-79.54%-47.12%275.44%103.19%58.61%2254.25%203.13%737.65%1589.29%52.82%-57.45%-96.62%43.89%
Cost of Goods Sold00000013.61M94.63M023.73M049.43M619K9.51M8.98M000017.23M
COGS % of Revenue------231.63%629.05%-232.67%-67.24%2.43%350.15%433.98%----627.73%
Gross Profit00258K39.66M3.05M11.8M-7.73M-79.59M13.47M-13.53M4.2M24.09M24.85M-6.79M-6.91M46.35M1.08M896K247K-14.48M
Gross Margin %--100%100%100%100%-131.63%-529.05%100%-132.67%100%32.76%97.57%-250.15%-333.98%100%100%100%100%-527.73%
Gross Profit Growth %-100%-100%103.34%149.83%-77.37%187.24%-283.92%-430.41%-45.81%-99.12%160.84%-48.03%2197.04%-858.26%-2897.57%420.1%52.82%-57.45%102.22%-859.36%
Operating Expenses6.91M9.93M7.8M8.25M10.96M14.25M7M-57.87M32.06M5.53M18.19M-26.44M26.79M6.1M7.32M20.43M12.92M26.98M30.45M13.02M
OpEx % of Revenue--3021.71%20.81%359.71%120.71%119.15%-384.64%238.04%54.26%432.59%-35.97%105.16%224.45%353.65%44.07%1193.72%3010.71%12329.55%474.53%
Selling, General & Admin3.72M6.49M4.89M4.3M4.17M5.88M6.82M7.06M5.2M5.53M5.92M6.43M5.71M6.1M7.32M6.5M6.63M8.05M15.3M13.02M
SG&A % of Revenue--1894.19%10.84%136.94%49.81%116.17%46.9%38.59%54.26%140.75%8.75%22.41%224.45%353.65%14.01%612.94%898.55%6196.36%474.53%
Research & Development3.2M3.43M2.91M5.59M8.6M10.67M13.61M28.84M26.86M23.73M17.33M16.56M16.39M9.51M8.98M15.09M7.36M8.17M16.97M17.32M
R&D % of Revenue--1127.52%14.1%282.05%90.43%231.63%191.68%199.45%232.67%412.27%22.52%64.35%350.15%433.98%32.55%680.22%912.17%6870.85%631.38%
Other Operating Expenses000-1000K-1000K-1000K-1000K-1000K0-1000K-1000K-1000K1000K-1000K-1000K-1000K-1000K1000K-1000K-1000K
Operating Income-6.91M-9.93M-7.54M31.41M-7.92M-2.44M-14.73M-21.73M-18.59M-19.06M-13.98M50.53M-1.93M-12.89M-14.23M25.92M-11.83M-26.08M-30.21M-27.5M
Operating Margin %---2921.71%79.19%-259.71%-20.71%-250.78%-144.41%-138.04%-186.93%-332.59%68.73%-7.59%-474.59%-687.63%55.93%-1093.72%-2910.71%-12229.55%-1002.26%
Operating Income Growth %12.67%-306.14%48.83%244.56%57.42%87.18%-5.36%-142.99%-861.38%-47.87%1.72%94.92%83.66%50.58%52.9%194.26%47.46%-40.65%-55.68%-46.32%
EBITDA-6.91M-9.55M-7.2M31.78M-7.92M-2.44M-14.73M-20.85M-18.59M-19.06M-12.67M50.57M-1.83M-12.78M-14.11M26.05M-11.58M-25.79M-30.02M-27.31M
EBITDA Margin %---2791.86%80.14%-259.69%-20.7%-250.77%-138.58%-138.03%-186.91%-301.36%68.78%-7.17%-470.62%-682.17%56.2%-1069.96%-2877.9%-12153.04%-995.3%
EBITDA Growth %12.67%-290.91%51.1%252.44%57.42%87.18%-16.27%-141.23%-918.13%-49.11%10.24%94.1%84.23%50.43%52.98%195.39%48.26%-40.19%-55.99%-46.79%
D&A (Non-Cash Add-back)000050050050002K2K038K108K108K113K129K257K294K189K191K
EBIT-6.91M-9.55M-7.2M31.78M-7.33M-2.36M-14.56M-20.85M-17.44M-17.86M-12.67M50.53M3.37M-12.89M-14.23M26.77M-11.68M-28.57M-30.34M-27.5M
Net Interest Income-2.37M377K336K376K532K740K864K1.03M1.18M1.2M1.33M1.04M950K982K963K715K208K-6K-2.42M-1.86M
Interest Income912K377K336K376K532K740K864K1.03M1.18M1.2M1.33M1.04M950K982K963K715K208K111K72K76K
Interest Expense3.28M0000000000000000117K2.49M1.94M
Other Income/Expense-37.37M374K335K376K534K744K865K1.13M1.16M1.2M1.31M1.05M940K976K961K847K159K-2.6M-2.62M-1.74M
Pretax Income-44.28M-9.55M-7.2M31.78M-7.38M-1.7M-13.87M-20.6M-17.44M-17.86M-12.67M51.58M-994K-11.91M-13.27M26.77M-11.68M-28.68M-32.83M-29.24M
Pretax Margin %---2791.86%80.14%-242.19%-14.4%-236.06%-136.92%-129.46%-175.17%-301.36%70.15%-3.9%-438.66%-641.18%57.75%-1079.02%-3201.12%-13291.09%-1065.6%
Income Tax000261K000290K-290K00387K2.21M0000000
Effective Tax Rate %0%0%0%0.82%0%0%0%-1.41%1.66%0%0%0.75%-222.43%0%0%0%0%0%0%0%
Net Income-44.28M-9.55M-7.2M31.52M-7.38M-1.7M-13.87M-20.89M-17.15M-17.86M-12.67M51.19M-3.21M-11.91M-13.27M26.77M-11.68M-28.68M-32.83M-29.24M
Net Margin %---2791.86%79.48%-242.19%-14.4%-236.06%-138.85%-127.31%-175.17%-301.36%69.63%-12.58%-438.66%-641.18%57.75%-1079.02%-3201.12%-13291.09%-1065.6%
Net Income Growth %-499.81%-461.88%48.05%250.9%56.95%90.48%-9.45%-140.8%-435.01%-49.92%4.5%91.22%72.55%58.46%59.59%191.56%48.16%-54.44%-69.02%-57.33%
Net Income (Continuing)-44.28M-9.55M-7.2M31.52M-7.38M-1.7M-13.87M-20.89M-17.15M-17.86M-12.67M51.19M-3.21M-11.91M-13.27M26.77M-11.68M-28.68M-32.83M-29.24M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.76-0.16-0.130.53-0.13-0.03-0.25-0.39-0.32-0.33-0.240.96-0.06-0.23-0.230.55-0.33-0.87-1.09-0.91
EPS Growth %-484.62%-428.05%48%235.9%59.38%90.82%-4.17%-140.63%-426.32%-43.48%-4.35%74.55%81.58%73.56%78.9%160.44%52.86%-38.1%-65.15%-33.82%
EPS (Basic)-0.76-0.16-0.130.56-0.13-0.03-0.25-0.39-0.32-0.33-0.240.97-0.06-0.23-0.230.55-0.33-0.87-1.09-0.91
Diluted Shares Outstanding58.23M57.97M57.28M59.37M56.28M56.03M55.38M54.04M54.12M53.96M53.52M53.11M52.71M52.57M52.53M48.72M35.88M32.98M32.61M32.13M
Basic Shares Outstanding58.23M57.97M57.28M56.02M56.28M56.03M55.38M54.04M54.12M53.96M53.52M53M52.71M52.57M52.53M48.72M35.88M32.98M32.5M32.13M
Dividend Payout Ratio--------------------